FDA's Gottlieb 'extremely worried' about how to pay for CAR-T therapies - STAT

FDA's Gottlieb 'extremely worried' about how to pay for CAR-T therapies - STAT

STAT Plus: Gottlieb ‘extremely worried’ about how to pay for CAR-T therapies

By IKE SWETLITZ

MICHAEL REYNOLDS/EPA

His comments are the strongest indication that the FDA might have a role in the debate over paying for the CAR-T therapies.

READ MORE